The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001204.7(BMPR2):c.2352C>T (p.Val784=)

CA2061522

333647 (ClinVar)

Gene: BMPR2 (HGNC:659)
Condition: pulmonary arterial hypertension (MONDO:0015924)
Inheritance Mode: Autosomal dominant inheritance
UUID: 56885255-cd86-4c5d-887f-dfd7f2b7ad29
Approved on: 2026-04-10
Published on: 2026-04-10

HGVS expressions

NM_001204.7:c.2352C>T
NM_001204.7(BMPR2):c.2352C>T (p.Val784=)
NC_000002.12:g.202556017C>T
CM000664.2:g.202556017C>T
NC_000002.11:g.203420740C>T
CM000664.1:g.203420740C>T
NC_000002.10:g.203128985C>T
NG_009363.1:g.184691C>T
ENST00000374580.10:c.2352C>T
ENST00000638587.1:c.2283C>T
ENST00000374574.2:c.1586+3129C>T
ENST00000374580.8:c.2352C>T
NM_001204.6:c.2352C>T
More

Uncertain Significance

Met criteria codes 3
PM2_Supporting BP7 BP4
Not Met criteria codes 4
PS4 BA1 PM1 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Pulmonary Hypertension Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for BMPR2 Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Pulmonary Hypertension VCEP
The NM_001204.7(BMPR2) c.2352C>T variant is a synonymous (silent) variant (p.Val784=). This variant is present in gnomADv2.1.1 controls at a frequency of 0.00002 and gnomADv4.1 at 0.00006 (PM2_supporting). In silico prediction algorithms indicate that the nucleotide is not highly conserved (REVEL score not available; CADD = 1.4; phyloP = 0.207) (BP4) and has no impact on splicing (SpliceAI = 0) (BP7). In summary, this variant is classified as a variant of uncertain significance for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: BP4, BP7, PM2_supporting. (VCEP specifications version 2.0, 1/30/2026)
Met criteria codes
PM2_Supporting
Maximum allele frequency is 0.00002 in gnomAD v2.1.1 controls and 0.00006 in gnomAD v4.1.
BP7
BP4 is met and the SpliceAI score (0) predicts no impact on splicing.
BP4
REVEL score not available. CADD = 1.4 is below the PH VCEP established threshold for benignity of <= 10.
Not Met criteria codes
PS4
Very low allele frequency and not reported in the literature.
BA1
Variant has less than 5% allele frequency.
PM1
No functional domain using UniProt and NextProt.
BS1
Allele frequency is not greater due to disorder.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.